L26/P-818 A randomized double-blind controlled trial on the effect of vitamin D on ovulation rate of anovulatory women with polycystic ovary syndrome (PCOS)
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Ko und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does vitamin D supplementation improve the ovulation rate in anovulatory women with polycystic ovary syndrome (PCOS)? Summary answer Vitamin D supplementation did not improve the ovulation rate in anovulatory women with PCOS. What is known already Vitamin D deficiency is prevalent among women with PCOS, a common reproductive endocrine disorder. Women with PCOS often present with ovulatory dysfunction. Some studies have shown that vitamin D deficiency may be related to abnormal development of ovarian follicles and regularity of menstrual cycles in these women. Study design, size, duration This was a multi-centre, randomised, double-blind, controlled clinical trial. Participants/materials, setting, methods Women aged 18-40 years with PCOS by the Rotterdam criteria and infrequent/no ovulation were recruited from five reproductive endocrinology centres. They were randomly assigned to the vitamin D group or placebo group. Those in the vitamin D group took oral Vitamin D3 50,000IU/week for 4 weeks, followed by 50,000IU every 2 weeks for 52 weeks. Those who were anovulatory after 6 months were given letrozole for ovulation induction. The primary outcome was the ovulation rate. Main results and the role of chance 220 women (110 women in each group) were recruited. The median age of the women was 30 (25th-75thpercentile 27-34) years. The median cycle length was 55 (25th-75th percentile 43-80) days. At 12 months, there were no significant differences in the ovulation rate between the vitamin D group and placebo group (p > 0.05). [EN1] There were no significant difference in the hormonal parameters and pregnancy rate between the two groups. Limitations, reasons for caution Ovulation and not livebirth was used as the primary outcome. Our study was not designed to detect small differences in the pregnancy or livebirth rates and some women may not be actively seeking pregnancy. Wider implications of the findings Although vitamin D is widely recommended for reproductive age women seeking fertility, vitamin D supplementation did not improve the ovulation rate in women with PCOS in our study. Trial registration number Yes
Zitieren
APA
Ko, J., Lai, S., Wan, R., Wong, C., Cheung, C., Chan, T., Li, R., & Ng, E. (2026). L26/P-818 A randomized double-blind controlled trial on the effect of vitamin D on ovulation rate of anovulatory women with polycystic ovary syndrome (PCOS). Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1145
Vancouver
Ko J, Lai S, Wan R, Wong C, Cheung C, Chan T, et al. L26/P-818 A randomized double-blind controlled trial on the effect of vitamin D on ovulation rate of anovulatory women with polycystic ovary syndrome (PCOS). Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1145
BibTeX
@article{Ko2026,
author = {Ko, J. and Lai, S.F. and Wan, R.S.F. and Wong, C.K.Y. and Cheung, C.L. and Chan, T.O. and Li, R.H.W. and Ng, E.H.Y.},
title = {L26/P-818 A randomized double-blind controlled trial on the effect of vitamin D on ovulation rate of anovulatory women with polycystic ovary syndrome (PCOS)},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1145}
}
EUVIMED